Amphastar Pharmaceuticals General Counsel Jason Shandell's 2020 pay jumps 132% to $6.8M
Amphastar Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 14, 2021
Amphastar Pharmaceuticals reported fiscal year 2020 executive compensation information on April 14, 2021.
In 2020, six executives at Amphastar Pharmaceuticals received on average a compensation package of $3.5M, a 15% increase compared to previous year.
Average pay of disclosed executives at Amphastar Pharmaceuticals
Jason B. Shandell, General Counsel, received $6.8M in total, which increased by 132% compared to 2019.
For fiscal year 2020, the median employee pay was $46,374 at Amphastar Pharmaceuticals. Therefore, the ratio of Jason B. Shandell's pay to the median employee pay was 146 to one.
Jack Yongfeng Zhang, Chief Executive Officer, received a compensation package of $6M, which is about the same as previous year. 33% of the compensation package, or $2M, was in option awards.
Mary Ziping Luo, Chief Operating Officer, earned $3M in 2020, a 1% increase compared to previous year.
William J. Peters, Chief Financial Officer, received $2.1M in 2020, which increases by 9% compared to 2019.
Rong Zhou, Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc, earned $1.5M in 2020, a 28% increase compared to previous year.
Jacob Liawatidewi, Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S, received $1.4M in 2020.
Related executives
Jack Zhang
Amphastar Pharmaceuticals
Chief Executive Officer
William Peters
Amphastar Pharmaceuticals
Chief Financial Officer
Mary Luo
Amphastar Pharmaceuticals
Chief Operating Officer
Jason Shandell
Amphastar Pharmaceuticals
General Counsel
Rong Zhou
Amphastar Pharmaceuticals
Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc
Jacob Liawatidewi
Amphastar Pharmaceuticals
Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S
You may also like
Source: SEC filing on April 14, 2021.